Materialise Completes Euronext Brussels Listing, Founders Support with Trading Arrangement.

Materialise, a global leader in 3D-printed medical devices and software, has successfully launched on Euronext Brussels, complementing its Nasdaq listing. The company's founders, Fried Vancraen and Hilde Ingelaere, have entered into a trading arrangement to sell up to 590,000 shares, approximately 1% of the total outstanding shares. The founders will maintain their ownership interest and focus on the company's continuity, growth, and long-term success.